Bridger Management »

Hillevax shares owned by Bridger Management

Quarter-by-quarter ownership of Hillevax (HLVX) shares owned by Bridger Management from 13F filings

Historical chart of Bridger Management investment in Hillevax

Tip: Access up to 7 years of quarterly data

All positions including Hillevax held by Bridger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hillevax by Bridger Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 108k 16.63

More positions owned by Bridger Management

Uber Technologies (UBER)
Eli Lilly & Co. (LLY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Morgan Stanley Com New (MS)
Vertex Pharmaceuticals Incorporated (VRTX)
Bath &#38 Body Works In (BBWI)
Endeavor Group Hldgs Cl A Com (EDR)
Pfizer (PFE)
Tenet Healthcare Corp Com New (THC)
Alnylam Pharmaceuticals (ALNY)
Springworks Therapeutics (SWTX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Caesars Entertainment (CZR)
Xenon Pharmaceuticals (XENE)
Melco Resorts And Entmnt Adr (MLCO)

View all positions for Bridger Management

Top funds holding Hillevax

Frazier Life Sciences Management
Deerfield Management Company
T. Rowe Price Investment Management
VR Adviser
Franklin Resources
Carlyle
BlackRock
Vanguard Group
StepStone
Samsara BioCapital
Millennium Management
Citadel Advisors
Geode Capital Management
Qiming U.S. Ventures Management
Deutsche Bank Aktiengesellschaft

View all funds holding Hillevax